Glucoryl-MV1 Tablet SR
Glucoryl-MV1 Tablet SR
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glimison-VM 1 Tablet SR
Unison Pharmaceuticals Pvt Ltd
Voglibose 0.2mg
Pack Size
1 units
Price
Save ₹180
that's 85% off!
About This Medicine
Product description & overview
Glucoryl-MV1 Tablets: A Comprehensive Treatment Solution
Glucoryl-MV1 Tablets are a once-daily combination medication specifically formulated to effectively manage type 2 diabetes. Each tablet contains a carefully balanced dose of Glimepiride (1mg), Metformin (500mg), and Voglibose (0.2mg) - three essential components for optimal blood sugar control.
Glimepiride: A sulfonylurea medication that stimulates the release of insulin from the pancreas, improving glucose uptake by cells.
Metformin: A biguanide-based drug that inhibits hepatic gluconeogenesis and enhances insulin sensitivity, effectively lowering blood glucose levels.
Voglibose: An α-glucosidase inhibitor that prevents the breakdown of carbohydrates in the digestive tract, promoting optimal blood sugar control after meals.
Glucoryl-MV1 Tablets offer a convenient and effective approach to managing type 2 diabetes by targeting various metabolic pathways involved in glucose regulation. Always consult with your healthcare provider before starting any new medication regimen.
Note: This description is for informational purposes only and does not constitute medical advice. Always follow the instructions of your physician or pharmacist.
Active composition
Glimepiride 1 mg
+2 more active ingredients
About Glimepiride
Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
All Active Ingredients
Voglibose
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Glucoryl-MV1 Tablet SR.
High Risk
Pregnancy
Glucoryl-MV1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Glucoryl-MV1 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glucoryl-MV1 Tablet SR may be needed. Please consult your doctor. Glucoryl-MV1 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Glucoryl-MV1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Glucoryl-MV1 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glucoryl-MV1 Tablet SR is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Glucoryl-MV1 Tablet SR
Products matching your search
Levialfa 500 Tablet
Levialfa 500 Tablet
Chemorab-DSR Capsule
Chemorab-DSR Capsule
Levexx 500 Tablet
Levexx 500 Tablet
Gluconorm-G Plus 2 Tablet PR
Gluconorm-G Plus 2 Tablet PR
Lamitor OD 100 Tablet SR
Lamitor OD 100 Tablet SR
Glucoryl-MV 2 Tablet SR
Glucoryl-MV 2 Tablet SR
Levera 250 Tablet
Levera 250 Tablet
Macorate CR 300 Tablet